Picture of Inogen logo

INGN Inogen Cashflow Statement

0.000.00%
us flag iconLast trade - 00:00
HealthcareAdventurousSmall CapSuper Stock

Annual cashflow statement for Inogen, fiscal year end - December 31st, USD millions except per share, conversion factor applied.

2020
December 31st
2021
December 31st
2022
December 31st
2023
December 31st
2024
December 31st
Period Length:12 M12 M12 M12 M12 M
Source:10-K10-K10-K10-K10-K
Standards:
USG
USG
USG
USG
USG
Status:FinalFinalFinalFinalFinal
Net Income/Starting Line-5.83-6.33-83.8-102-35.9
Depreciation
Deferred Taxes
Non-Cash Items24.41467.46726.3
Unusual Items
Other Non-Cash Items
Changes in Working Capital-0.031-20.1-44.714.3-4.39
Change in Accounts Receivable
Change in Inventories
Change in Prepaid Expenses
Change in Other Assets
Change in Accrued Expenses
Change in Payable / Accrued Expenses
Change in Taxes Payable
Change in Other Liabilities
Cash from Operating Activities3723.6-37.5-3.235.91
Capital Expenditures-17.6-24.1-21.2-27-17.1
Purchase of Fixed Assets
Purchase / Acquisition of Intangibles
Other Investing Cash Flow Items-8.049.4210.3-32.33.12
Acquisition of Business
Sale/Maturity of Investment
Purchase of Investments
Cash from Investing Activities-25.6-14.6-10.9-59.3-14
Financing Cash Flow Items1.731.30.3360.5760.265
Other Financing Cash Flow
Net Issuance / Retirement of Stock
Cash from Financing Activities2.07150.380.960.265
Foreign Exchange Effects
Beginning Cash Balance
Ending Cash Balance
Net Change in Cash13.923.6-48.5-61.5-8.08